Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'c jun peptide'

Search results for: 'c jun peptide'

Items 11-20 of 76

Page
per page
  1. Olcegepant
    A3680 Olcegepant
    Target: CGRP receptors
    Summary: Non-peptide receptor of CGRP,first potent and selective
      ≥87 mg/mL
  2. DAPT (GSI-IX)
    A8200 DAPT (GSI-IX)
     6 Citation
    Summary: γ-secretase inhibitor,potent and specific
      ≥21.62 mg/mL
  3. Gap 26
    A1044 Gap 26
     8 Citation
    Target: Gap Junctions
    Summary: Gap junction blocker peptide, mapping to connexin 43 residue 63-75
      insoluble in EtOH; ≥155.1 mg/mL
  4. Ki20227
    A3527 Ki20227
    Target: c-Fms tyrosine kinase
    Summary: C-Fms tyrosine kinase inhibitor
      ≥48.1 mg/mL
  5. T-5224
    B4664 T-5224
     10 Citation
    Target: AP-1|MMP
    Summary: C-Fos/AP-1 inhibitor
      ≥25.88 mg/mL
  6. GW5074
    B1405 GW5074
    Summary: C-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥21.9 mg/mL
  7. GSK1070916
    A4127 GSK1070916
    Target: Aurora Kinases
    Summary: Aurora B/C inhibitor
      ≥25.4 mg/mL
  8. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive
  9. PF-04217903 methanesulfonate
    A3712 PF-04217903 methanesulfonate
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      Soluble in DMSO
  10. (R)-Crizotinib
    A3020 (R)-Crizotinib
     2 Citation
    Target: c-MET
    Summary: C-MET/ALK inhibitor,potent and ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL

Items 11-20 of 76

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 75item
  2. Lab Reagents 1 item
Reversibility
  1. Reversible 6item
  2. Irreversible 1 item
Target
  1. Proteasome 4item
  2. Bcl-2 1 item
  3. CXCR 1 item
  4. Raf 7item
  5. Aurora Kinases 2item
  6. Gap Junctions 2item
  7. Bromodomains 1 item
  8. AP-1 1 item
  9. MMP 1 item
  10. FLT3 4item
  11. Eph Receptors 1 item
  12. VEGFR 12item
  13. PDGFR 8item
  14. c-Kit 6item
  15. RET 1 item
  16. Thymidylate Synthase 1 item
  17. JNK 1 item
  18. Bcr-Abl 1 item
  19. FGFR 2item
  20. CGRP receptors 1 item
  21. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  22. MET 5item
  23. Src 1 item
  24. Trk Receptors 2item
  25. STAT 1 item
  26. Microtubules/Tubulins 1 item
  27. FAK 1 item
  28. AMPK 1 item
  29. Angiotensin AT2 Receptors 1 item
  30. c-MET 7item
  31. PKC 3item
  32. Calpains 1 item
  33. HCV Proteases 1 item
  34. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  35. Lyn 1 item
  36. Melanocortin (MC) Receptors 1 item
  37. HIV-1 gp120 1 item
  38. Tie-2 1 item
  39. C5a receptors 1 item
  40. Farnesyl Diphosphate Synthases 1 item
  41. Ron 1 item
  42. Synthases/Synthetases 1 item
  43. NPY Receptors 1 item
  44. DPP-4 1 item
  45. c-Fms tyrosine kinase 1 item
  46. HCV polymerase 1 item
  47. PC-PLC 1 item
  48. Substance P/NK1 Receptor 1 item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 1 item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 9item
  7. Cancer 44item
  8. Cholangiocarcinoma 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 6item
  11. Colon Carcinoma 2item
  12. Colorectal Cancer 7item
  13. Diabetes 2item
  14. Glioblastoma 3item
  15. Glioma 1 item
  16. HCV 1 item
  17. Hepatitis C 1 item
  18. Hepatocellular Carcinoma 1 item
  19. HIV 1 item
  20. Inflammatory Diseases 1 item
  21. Leukemia 2item
  22. Liver Cancer 1 item
  23. Lung Cancer 6item
  24. Lung Carcinoma 2item
  25. Lymphoma 2item
  26. Melanoma 5item
  27. Multiple Myeloma 2item
  28. Non-small Cell Lung Cancer 2item
  29. Ovarian Cancer 3item
  30. Pancreatic Cancer 7item
  31. Prostate Cancer 3item
  32. Renal Cell Carcinoma 4item
  33. Rheumatoid Arthritis 1 item
  34. Thyroid Cancer 4item
  35. Type 2 Diabetes 1 item